Integra LifeSciences Corporation: FDA filings under this applicant name
FDA lists 94 510(k) clearances under 2 spellings of the applicant name “Integra LifeSciences Corporation” (first 1999, latest 2025), plus 7 PMA decisions, across 34 product codes in 7 review panels. Median 510(k) review time under this name: 82 days. Since 2017 the median was 84 days, against 112 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Integra LifeSciences, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 5 | 112 |
| 2013 | 3 | 127 |
| 2014 | 8 | 120 |
| 2015 | 3 | 276 |
| 2016 | 6 | 134 |
| 2017 | 3 | 28 |
| 2018 | 7 | 91 |
| 2019 | 5 | 59 |
| 2020 | 3 | 90 |
| 2021 | 2 | 233 |
| 2022 | 2 | 44 |
| 2023 | 1 | 144 |
| 2024 | 1 | 142 |
| 2025 | 2 | 102 |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Integra LifeSciences Corporation took a median 84 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 112 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JXG | Shunt, Central Nervous System And Components | 14 | 14 |
| LFL | Instrument, Ultrasonic Surgical | 13 | 13 |
| HBL | Holder, Head, Neurosurgical (Skull Clamp) | 10 | 10 |
| GWM | Device, Monitoring, Intracranial Pressure | 8 | 8 |
| KGN | Wound Dressing With Animal-Derived Material(S) | 7 | 7 |
| GXQ | Dura Substitute | 6 | 6 |
| HRS | Plate, Fixation, Bone | 5 | 5 |
| JXI | Cuff, Nerve | 4 | 4 |
| PHX | Shoulder Prosthesis, Reverse Configuration | 4 | 4 |
| MQV | Filler, Bone Void, Calcium Compound | 3 | 3 |
Plus 24 more product codes.
Review panels
- Neurology (52)
- General and Plastic Surgery (27)
- Orthopedic (15)
- Dental (3)
- Obstetrics and Gynecology (2)
- Cardiovascular (1)
- Ophthalmic (1)
Most recent Integra LifeSciences Corporation 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K251162 | CUSA® Clarity Ultrasonic Surgical Aspirator System | LFL | 2025-10-08 | 176 |
| K250752 | AURORA® Surgiscope® System (ASX15/60); AURORA® Surgiscope® System (ASX15/80) | GWG | 2025-04-09 | 28 |
| K240493 | CUSA® Clarity Ultrasonic Surgical Aspirator System | LFL | 2024-07-11 | 142 |
| K230427 | CUSA Clarity Ultrasonic Surgical Aspirator System | LFL | 2023-07-11 | 144 |
| K221835 | CUSA Clarity Ultrasonic Surgical Aspirator System | LFL | 2022-08-22 | 60 |
| K221763 | CUSA Clarity Ultrasonic Surgical Aspirator System | LFL | 2022-07-15 | 28 |
| K210128 | INTEGRA Wound Matrix (Macro-Channels) | KGN | 2021-10-08 | 262 |
| K210016 | Integra DigiFuse Cannulated Intramedullary Fusion System,Integra Total Foot System,Integra CAPTURE Screw System & Integra Ti6 Internal Fixation System,Subtalar MBA System,MetaSurg Subtalar Implant,NewDeal BOLD Screw,NewDeal HALLU Lock Plate System,NewDeal HALLU Plates,QWIX Positioning Screw,SPIN Snap-Off Screw,NewDeal TIBIAXYS System | HRS | 2021-07-27 | 204 |
| K193346 | Codman Surgical Patties & Strips | HBA | 2020-11-20 | 353 |
| K201507 | Cadence Total Ankle System | HSN | 2020-06-29 | 24 |
84 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P080013 | PMA | DURASEAL EXACT SPINE SEALANT SYSTEM | 2009-09-04 |
| P040034 | PMA | DURASEAL DURAL SEALANT SYSTEM | 2005-04-07 |
| P900033 | PMA | INTEGRA DERMAL REGENERATION TEMPLATE | 1996-03-01 |
| P840062 | PMA | COLLACOTE(TM) | 1985-11-08 |
| P850010 | PMA | HELISTAT(TM) ABSORBABLE COLLAGEN HEMOSTATIC SPONGE | 1985-11-08 |
Recalls
316 product recalls in 132 recall events; 63 initiated in the last five years. Most recent: 2025-02-06.
8 product recalls in 7 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 4 initiated in the last five years. Most often: Integra LifeSciences Corp. (NeuroSciences) (4), Integra Limited (3), Integra Neuro Sciences (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Integra LifeSciences Corporation is the lead sponsor of 70 device studies on ClinicalTrials.gov (5 active or recruiting). Most recent:
- NCT07805798: Urinary Bladder Matrix (UBM) Registry (Recruiting, started 2026-10-23)
- NCT06629506: MicroMatrix® Flex in Tunneling Wounds (Completed, started 2024-12-12)
- NCT06453187: A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers (Enrolling by invitation, started 2024-11-18)
- NCT06276543: Bactiseal Catheter Safety Registry Study (Recruiting, started 2024-09-29)
- NCT06297187: Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study (Completed, started 2024-02-23)
Parent company SEC filings
INTEGRA LIFESCIENCES HOLDINGS CORP (IART): EDGAR filings, CIK 917520. Caduvo groups Integra LifeSciences Corporation under Integra LifeSciences; the parent's SEC registrant is entered by hand for the group, not matched by name.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Integra LifeSciences Corporation (69)
- Integra Lifesciences Corp. (32)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Integra Neurocare, LLC (12 510(k)s)
- Integra Radionics, Inc. (10 510(k)s)
- Integra Lifesciences Production Corporation (9 510(k)s)
- Integra Neurosciences (8 510(k)s)
- Integra Neurosciences Implants S.A. (6 510(k)s)
- Integra Life Sciences (3 510(k)s)
- Integra Lifescience Corportation (2 510(k)s)
- Integra Medical (2 510(k)s)
- Integra Biotechnical, LLC (1 510(k)s)
- Integra Burlington Ma, Inc. (1 510(k)s)
- Integra Burlington Ma, Inc. (Formerly Integra Radi (1 510(k)s)
- Integra Lifesciences Corporation (Owner of Tei Biosciences) (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Integra LifeSciences Corporation?
FDA lists 94 510(k) clearances under 2 spellings of the applicant name “Integra LifeSciences Corporation” (first 1999, latest 2025), plus 7 PMA decisions, across 34 product codes in 7 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Integra LifeSciences Corporation?
The median time from FDA receipt to decision across 510(k)s cleared under the name Integra LifeSciences Corporation is 82 days. Since 2017: 84 days, versus 112 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Integra LifeSciences Corporation?
The most frequent FDA product codes under this applicant name are JXG (Shunt, Central Nervous System And Components, 14); LFL (Instrument, Ultrasonic Surgical, 13); HBL (Holder, Head, Neurosurgical (Skull Clamp), 10).
Next steps
- See all 94 Integra LifeSciences Corporation clearances with predicates and recalls
- Run predicate analysis for product code JXG, Integra LifeSciences Corporation's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.